Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology-Clinical Diagnosis: Neuroendocrine

90Y-DOTATOC therapy in patients with metastatic radioiodine negative differentiated thyroid cancer: Preliminary results

Annibale Versari, Angelina Filice, Andrea Frasoldati, Nadia Cremonini, Mattia Asti, Federica Fioroni, Alessandro Fraternali, Massimiliano Casali and Diana Salvo
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 403;
Annibale Versari
1Nuclear Medicine, S.Maria Nuova Hospital, Reggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelina Filice
1Nuclear Medicine, S.Maria Nuova Hospital, Reggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Frasoldati
2Endocrinology, S.Maria Nuova Hospital, Reggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadia Cremonini
3Endocrinology, Maggiore-Bellaria Hospital, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mattia Asti
1Nuclear Medicine, S.Maria Nuova Hospital, Reggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Federica Fioroni
4Medical Physics, S.Maria Nuova Hospital, Reggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandro Fraternali
1Nuclear Medicine, S.Maria Nuova Hospital, Reggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimiliano Casali
1Nuclear Medicine, S.Maria Nuova Hospital, Reggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diana Salvo
1Nuclear Medicine, S.Maria Nuova Hospital, Reggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 51 no. supplement 2 403

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2010

Author Information

  1. Annibale Versari1,
  2. Angelina Filice1,
  3. Andrea Frasoldati2,
  4. Nadia Cremonini3,
  5. Mattia Asti1,
  6. Federica Fioroni4,
  7. Alessandro Fraternali1,
  8. Massimiliano Casali1 and
  9. Diana Salvo1
  1. 1Nuclear Medicine, S.Maria Nuova Hospital, Reggio Emilia, Italy
  2. 2Endocrinology, S.Maria Nuova Hospital, Reggio Emilia, Italy
  3. 3Endocrinology, Maggiore-Bellaria Hospital, Bologna, Italy
  4. 4Medical Physics, S.Maria Nuova Hospital, Reggio Emilia, Italy

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: January 2015 to April 2025

AbstractFullPdf
Jan 2015100
Apr 2015100
May 2015100
Jun 2015300
Jul 2015100
Aug 2015300
Sep 2015500
Feb 2016100
Jun 2016300
Oct 2016300
Nov 2016100
Dec 2016200
Jan 2017300
May 2017200
Jun 2017800
Sep 2017100
Oct 2017300
Mar 2018300
Apr 2018100
Jun 2018100
Sep 2018200
Oct 2018100
Nov 2019300
Jan 2020100
Feb 2020400
Mar 20201300
Apr 2020900
May 2020300
Jul 2020100
Aug 20202300
Sep 20201900
Oct 2020900
Nov 20201600
Dec 2020600
Jan 2021300
Feb 20211000
Mar 2021700
Apr 2021900
May 2021800
Jun 2021300
Jul 20211200
Aug 20212100
Sep 2021800
Oct 2021700
Nov 20213600
Dec 20212700
Jan 20223200
Feb 20221300
Mar 2022900
Apr 2022300
May 20221200
Jun 2022300
Aug 2022100
Sep 2022100
Oct 2022300
Nov 2022100
Dec 2022300
Jan 2023300
Feb 2023200
Mar 2023200
Apr 2023200
May 2023500
Jun 2023300
Jul 2023200
Aug 2023200
Sep 2023300
Oct 2023300
Nov 2023200
Dec 2023500
Jan 2024200
Feb 2024200
Mar 2024200
Apr 2024200
May 2024200
Jun 2024600
Jul 2024100
Aug 20241300
Sep 20241000
Nov 2024100
Dec 2024500
Mar 2025300
Apr 2025100
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
90Y-DOTATOC therapy in patients with metastatic radioiodine negative differentiated thyroid cancer: Preliminary results
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
90Y-DOTATOC therapy in patients with metastatic radioiodine negative differentiated thyroid cancer: Preliminary results
Annibale Versari, Angelina Filice, Andrea Frasoldati, Nadia Cremonini, Mattia Asti, Federica Fioroni, Alessandro Fraternali, Massimiliano Casali, Diana Salvo
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 403;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
90Y-DOTATOC therapy in patients with metastatic radioiodine negative differentiated thyroid cancer: Preliminary results
Annibale Versari, Angelina Filice, Andrea Frasoldati, Nadia Cremonini, Mattia Asti, Federica Fioroni, Alessandro Fraternali, Massimiliano Casali, Diana Salvo
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 403;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology-Clinical Diagnosis: Neuroendocrine

  • Glucagon-like peptide-1 vs. somatostatin receptor targeting in malignant insulinoma
  • Detection of intestinal NET by (68)Ga-DOTATOC PET/multiphase CT
  • Somatostatin receptor expression in metastatic NET lesions depends on primary tumor site
Show more Oncology-Clinical Diagnosis: Neuroendocrine

Neuroendocrine Cancers

  • Comparison of 68Ga-DOTA-NOC and 18F-DOPA PET/CT in patients with neuroendocrine tumours (NETs)
  • Ga68-DOTANOC uptake in the pancreas: Pathological significance?
Show more Neuroendocrine Cancers

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire